You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models

Citation Tools

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Novel Single-Agent Immunotherapies
1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Shaler CR, Dhakal S, Choi YS, et al
1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1403-B